Position in ZTS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,705,910
-$16,861,258 QoQ
Shares Held
121,151
-44.0% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#257
of 1,412 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $43,412,538 across 29 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (20.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
121,151 | $8,705,910 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
45,360 | $7,644,974 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
9,855 | $5,339,734 | |
| 4 | VTRS |
Viatris Inc
|
197,717 | $3,139,745 | |
| 5 | HLN |
Haleon plc
|
263,202 | $2,455,674 | |
| 6 | HROW |
Harrow, Inc.
|
56,414 | $2,395,902 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
143,998 | $2,308,287 | |
| 8 | ALKS |
Alkermes plc.
|
42,278 | $2,215,367 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,705,910 | 121,151 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $25,567,168 | 216,286 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $24,668,646 | 196,063 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $32,120,020 | 219,519 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $61,302,697 | 393,092 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $81,118,444 | 492,672 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $16,081,353 | 98,701 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $15,674,360 | 80,225 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,278,623 | 82,364 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $14,939,212 | 88,288 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $19,087,060 | 96,707 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,802,466 | 96,577 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $13,813,825 | 80,215 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $13,597,815 | 81,698 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $15,104,322 | 103,066 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $14,605,230 | 98,491 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $16,168,317 | 94,062 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $18,379,415 | 97,457 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $20,827,716 | 85,349 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $16,144,488 | 83,159 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $15,562,178 | 83,506 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $10,549,900 | 66,992 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $12,314,358 | 74,407 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $12,569,608 | 76,009 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $12,073,635 | 88,103 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $11,030,259 | 93,723 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||